BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $38,000 | -84.3% | 12,255 | -81.7% | 0.00% | – |
| Q3 2021 | $242,000 | +30.1% | 67,099 | +29.0% | 0.00% | – |
| Q2 2021 | $186,000 | +100.0% | 51,995 | +118.3% | 0.00% | – |
| Q1 2021 | $93,000 | -92.6% | 23,818 | -92.0% | 0.00% | -100.0% |
| Q4 2020 | $1,255,000 | +518.2% | 298,774 | +456.8% | 0.00% | – |
| Q1 2020 | $203,000 | -92.6% | 53,661 | -87.7% | 0.00% | -100.0% |
| Q4 2019 | $2,750,000 | +1471.4% | 435,059 | +943.1% | 0.00% | – |
| Q3 2019 | $175,000 | -92.2% | 41,708 | -91.4% | 0.00% | -100.0% |
| Q2 2019 | $2,256,000 | -76.5% | 485,095 | -73.3% | 0.00% | -78.6% |
| Q1 2019 | $9,612,000 | +164.7% | 1,813,595 | +84.8% | 0.01% | +133.3% |
| Q4 2018 | $3,631,000 | +961.7% | 981,422 | +703.6% | 0.01% | – |
| Q3 2018 | $342,000 | -22.4% | 122,130 | -18.3% | 0.00% | -100.0% |
| Q2 2018 | $441,000 | +71.6% | 149,471 | +30.8% | 0.00% | – |
| Q1 2018 | $257,000 | -17.1% | 114,234 | +8.8% | 0.00% | – |
| Q4 2017 | $310,000 | +761.1% | 104,960 | +455.6% | 0.00% | – |
| Q1 2017 | $36,000 | -98.5% | 18,891 | -97.9% | 0.00% | -100.0% |
| Q3 2016 | $2,399,000 | -34.7% | 888,556 | -42.9% | 0.00% | -50.0% |
| Q2 2016 | $3,675,000 | -5.7% | 1,557,119 | +29.0% | 0.01% | -20.0% |
| Q1 2016 | $3,898,000 | +377.7% | 1,206,803 | +608.6% | 0.01% | +400.0% |
| Q4 2015 | $816,000 | +724.2% | 170,306 | +852.9% | 0.00% | – |
| Q3 2015 | $99,000 | -99.2% | 17,872 | -98.9% | 0.00% | -100.0% |
| Q2 2015 | $12,507,000 | -44.9% | 1,571,200 | -27.4% | 0.02% | -42.9% |
| Q1 2015 | $22,714,000 | +578.2% | 2,163,292 | +676.4% | 0.04% | +500.0% |
| Q4 2014 | $3,349,000 | -70.2% | 278,621 | -57.6% | 0.01% | -75.0% |
| Q3 2014 | $11,243,000 | +120.4% | 657,888 | +55.7% | 0.03% | +100.0% |
| Q2 2014 | $5,101,000 | +277.6% | 422,603 | +164.1% | 0.01% | +250.0% |
| Q1 2014 | $1,351,000 | -36.5% | 160,039 | -55.7% | 0.00% | -42.9% |
| Q4 2013 | $2,129,000 | +1206.1% | 361,543 | +1106.1% | 0.01% | +600.0% |
| Q3 2013 | $163,000 | – | 29,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
| EMC Capital Management | 193,906 | $758,000 | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
| ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
| Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
| Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
| SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
| Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |